TME presents what is defined by different cellular and non-cellular components(i.e., ECMs) in the tumor stroma.(Impact of Immune Cell Heterogeneity on HER2+ Breast Cancer Prognosis and Response to Therapy ). Here, ERBB2 is linked to breast carcinoma.